COMMUNIQUÉS West-GlobeNewswire

Axovant Sciences Announces Public Offering of Common Shares
13/03/2019
NEW YORK and BASEL, Switzerland, March 13, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (Nasdaq: AXGT) ("Axovant") today announced that it has commenced an underwritten public offering of its common shares. All of the [...]
Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
13/03/2019
SOUTH SAN FRANCISCO, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that Gerald [...]
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
13/03/2019
SAN DIEGO, March 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
miRagen Announces Fourth Quarter and Full Year 2018 Financial Results and Provides 2019 Outlook
13/03/2019
Cobomarsen tested in clinical trials for three different types of blood cancers Multiple clinical sites open and actively recruiting in the global Phase 2 SOLAR clinical trial of cobomarsen in CTCL Data from four [...]
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time
13/03/2019
BASKING RIDGE, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]
Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2018 Financial Results on March 28, 2019
13/03/2019
SOUTH SAN FRANCISCO, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi- [...]
Melinta Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
~ Reports Revenue of $96.4 million, Including Net Product Sales of $46.6 million, for the Full-Year 2018 ~ ~ Net Product Sales of $14.6 million for the Fourth Quarter of 2018, up 32 Percent from Prior Quarter ~ ~ [...]
Sanofi successfully prices EUR 2 billion of bond issues
13/03/2019
Sanofi successfully prices EUR 2 billion of bond issues Paris, France - March 13, 2019 - Sanofi announces that it has successfully priced its offering of EUR 2 billion of notes (the " Notes ") across 3 tranches: €850 [...]
Sanofi place des emprunts obligataires de 2 milliards d'euros
13/03/2019
Sanofi place des emprunts obligataires de 2 milliards d'euros Paris, France - Le 13 mars 2019 - Sanofi annonce avoir placé avec succès une émission obligataire en 3 tranches (les « Obligations ») pour un montant de 2 [...]
Crossject : Résultats annuels 2018 et point d'activité
13/03/2019
Communiqué de Presse Résultats annuels et point d’activité Premiers lots cliniques au printemps Confirmation du calendrier de dépôt d’AMM Signature d’accords de licence prévus en 2019 Nouvelles perspectives commerciales [...]
FlexDex Provides Improved Solution to Prostate Surgery in Italy
13/03/2019
BRIGHTON, Mich., March 13, 2019 (GLOBE NEWSWIRE) -- FlexDex Inc. an innovative medical device company that has developed a platform technology to provide surgeons with high-performance and cost-effective minimally [...]
EMA Grants Orphan Medicinal Product Designation for Retrotope’s RT001 in the Treatment of Infantile Neuroaxonal Dystrophy (INAD), a PLA2G6 associated neurodegeneration (PLAN)
13/03/2019
LOS ALTOS, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Retrotope received notification from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) that its request for orphan medicinal product [...]
NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)
13/03/2019
The shareholders of Active Biotech AB (publ) are invited to the Extraordinary Shareholders' Meeting to be held on Thursday April 4, 2019, at 5.00 pm in the Company's offices, Scheelevägen 22 in Lund, Sweden. ENTITLEMENT [...]
Active Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on April 4, 2019
13/03/2019
Lund Sweden, March 13 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that Active Biotech has entered into an agreement regarding sale of the Company's property Forskaren 1 in Lund, Sweden, with a newly formed [...]
Media Advisory: 6th Canadian Obesity Summit
13/03/2019
OTTAWA, March 13, 2019 (GLOBE NEWSWIRE) -- ATTENTION: Editors/journalists covering health, wellness, nutrition, exercise, healthcare, bariatrics, obesity, social justice, social equity, research, and science. WHAT: 6th [...]
Annual General Meeting in ALK-Abelló A/S held on 13 March 2019
13/03/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) held its annual general meeting on 13 March 2019. The annual general meeting transacted the following business: Adoption of the annual report 2018 and discharge of the Board [...]
CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences
13/03/2019
In a release issued earlier today by Acer Therapeutics Inc. (Nasdaq: ACER), please note in the table for the Roth Capital Partners 31 st Annual Growth Stock Conference, a time of 3:30 pm Pacific Time has been added for [...]
New study finds significant differences in how various adaptive servo ventilation (ASV) devices treat complex sleep apnea
13/03/2019
March 13, 2019 Using Philips PAP solutions, results resurface conversation around ASV therapy use for complex sleep apnea and its potential to improve quality of life Amsterdam, the Netherlands – Royal Philips (NYSE: [...]
Align Technology Showcases SmileView – an Online Tool for Prospective Invisalign Patients at 2019 International Dental Show
13/03/2019
SmileView Tool Helps People Visualize Their Straighter Smile Before They Start an Invisalign treatment COLOGNE, Germany and SAN JOSE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) [...]

Pages